Research programme: androgen receptor antagonists - Endoceutics

Drug Profile

Research programme: androgen receptor antagonists - Endoceutics

Alternative Names: EM-4350; EM-5855; EM-6537

Latest Information Update: 06 Jan 2016

Price : $50

At a glance

  • Originator Endoceutics
  • Class Steroids
  • Mechanism of Action Androgen receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Acne; Benign prostatic hyperplasia; Male pattern baldness; Prostate cancer

Most Recent Events

  • 06 Jan 2016 No recent reports on development identified - Preclinical for Male pattern baldness in Canada (Topical)
  • 06 Jan 2016 No recent reports on development identified - Preclinical for Benign prostatic hyperplasia in Canada (unspecified route)
  • 06 Jan 2016 No recent reports on development identified - Preclinical for Prostate cancer in Canada (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top